Cargando…

Recent advances in understanding Epstein-Barr virus

Epstein-Barr virus (EBV) is a common human herpes virus known to infect the majority of the world population. Infection with EBV is often asymptomatic but can manifest in a range of pathologies from infectious mononucleosis to severe cancers of epithelial and lymphocytic origin. Indeed, in the past...

Descripción completa

Detalles Bibliográficos
Autores principales:	Stanfield, Brent A., Luftig, Micah A.
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	F1000Research 2017
Materias:	Review
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5373418/ https://www.ncbi.nlm.nih.gov/pubmed/28408983 http://dx.doi.org/10.12688/f1000research.10591.1

Ejemplares similares

Recent Advances in Diagnostic Approaches for Epstein–Barr Virus
por: Abusalah, Mai Abdel Haleem, et al.
Publicado: (2020)

To Be or Not IIb: A Multi-Step Process for Epstein-Barr Virus Latency Establishment and Consequences for B Cell Tumorigenesis
por: Price, Alexander M., et al.
Publicado: (2015)

Identification of Host Biomarkers of Epstein-Barr Virus Latency IIb and Latency III
por: Messinger, Joshua E., et al.
Publicado: (2019)

Epstein-Barr virus (EBV)-associated miRNAs are important for the maintenance of EBV transformed B cells
por: Linnstaedt, Sarah, et al.
Publicado: (2010)

Epstein-Barr virus perpetuates B cell germinal center dynamics and generation of autoimmune-associated phenotypes in vitro
por: SoRelle, Elliott D., et al.
Publicado: (2022)

The Epstein-Barr Virus
por: Payne, L. N.
Publicado: (1980)

Epstein-Barr virus induces adhesion molecule CD226 (DNAM-1) expression during primary B cell transformation into lymphoblastoid cell lines
por: Grossman, Lisa V, et al.
Publicado: (2012)

Epstein-Barr virus evades restrictive host chromatin closure by subverting B cell activation and germinal center regulatory loci
por: SoRelle, Elliott D., et al.
Publicado: (2023)

Epstein–barr virus vaccines
por: Cohen, Jeffrey I
Publicado: (2015)

Epstein-Barr Virus Induces Adhesion Receptor CD226 (DNAM-1) Expression during Primary B-Cell Transformation into Lymphoblastoid Cell Lines
por: Grossman, Lisa, et al.
Publicado: (2017)

Understanding the interplay between host immunity and Epstein-Barr virus in NPC patients
por: Shen, Yong, et al.
Publicado: (2015)

MDM2-dependent inhibition of P53 is required for Epstein-Barr virus B cell growth transformation and infected cell survival
por: Forte, E, et al.
Publicado: (2009)

Epstein-Barr virus infection mechanisms
por: Chesnokova, Liudmila S., et al.
Publicado: (2014)

Epstein–Barr virus latent genes
por: Kang, Myung-Soo, et al.
Publicado: (2015)

Epstein-Barr virus and nasopharyngeal carcinoma
por: Young, Lawrence S., et al.
Publicado: (2014)

Epstein-Barr virus and Burkitt lymphoma
por: Rowe, Martin, et al.
Publicado: (2014)

Epstein-Barr Virus in Gastric Carcinoma
por: Nishikawa, Jun, et al.
Publicado: (2014)

Novel Therapeutics for Epstein–Barr Virus
por: Andrei, Graciela, et al.
Publicado: (2019)

Vaccination against the Epstein–Barr virus
por: Rühl, Julia, et al.
Publicado: (2020)

Epigenetic lifestyle of Epstein-Barr virus
por: Buschle, Alexander, et al.
Publicado: (2020)

Epstein–Barr Virus History and Pathogenesis
por: Yu, Hui, et al.
Publicado: (2023)

Limited nucleotide pools restrict Epstein–Barr virus-mediated B-cell immortalization
por: Hafez, A Y, et al.
Publicado: (2017)

The oncogenic role of Epstein–Barr virus‐encoded microRNAs in Epstein–Barr virus‐associated gastric carcinoma
por: Zhang, Jinglin, et al.
Publicado: (2017)

Advances in Virus-Directed Therapeutics against Epstein-Barr Virus-Associated Malignancies
por: Ghosh, Sajal K., et al.
Publicado: (2012)

Epstein-Barr Virus and Human Cancer
por: Young, Lawrence
Publicado: (2002)

Epstein–Barr virus and multiple sclerosis
por: Soldan, Samantha S., et al.
Publicado: (2022)

Potential Cellular Functions of Epstein-Barr Nuclear Antigen 1 (EBNA1) of Epstein-Barr Virus
por: Smith, Danielle Westhoff, et al.
Publicado: (2013)

Immunotherapy for Epstein-Barr Virus-Related Lymphomas
por: Kennedy-Nasser, Alana A., et al.
Publicado: (2009)

Epstein-Barr virus and the origin of Hodgkin lymphoma
por: Vockerodt, Martina, et al.
Publicado: (2014)

The Microenvironment in Epstein–Barr Virus-Associated Malignancies
por: Tan, Geok Wee, et al.
Publicado: (2018)

Stress-Induced Epstein-Barr Virus Reactivation
por: Sausen, Daniel G., et al.
Publicado: (2021)

Epstein-Barr virus ensures B cell survival by uniquely modulating apoptosis at early and late times after infection
por: Price, Alexander M, et al.
Publicado: (2017)

Protein Kinase CK2 and Epstein–Barr Virus
por: Montenarh, Mathias, et al.
Publicado: (2023)

Epstein–Barr Virus in the Development of Colorectal Cancer (Review)
por: Oleynikova, N.A., et al.
Publicado: (2021)

An ATM/Chk2-mediated DNA damage responsive signaling pathway suppresses Epstein-Barr virus transformation of primary human B cells
por: Nikitin, Pavel, et al.
Publicado: (2010)

Some recent developments in the molecular epidemiology of Epstein-Barr virus infections.
por: Miller, G., et al.
Publicado: (1987)

Progression of understanding for the role of Epstein-Barr virus and management of nasopharyngeal carcinoma
por: Nakanishi, Yosuke, et al.
Publicado: (2017)

Epstein-Barr Virus Gastritis
por: Oki, Masayuki, et al.
Publicado: (2017)

Epstein - Barr virus Pneumonitis
por: McManus, Terence E, et al.
Publicado: (2009)

Epstein–Barr virus vaccines
por: Cohen, Jeffrey I
Publicado: (2015)

Cannot write session to /tmp/vufind_sessions/sess_j4atli9hfdfpv6d2b4k75nb473